Inmar Intelligence Healthcare Team
Covid-19 is in the regulatory rearview for most of the Federal government and now the Federal Drug Administration is hyper focused on ensuring product safety throughout the pharmaceutical supply chain. This effort is manifesting itself in an exponential increase in FDA-executed facility inspections -- and resulting recalls.
More recalls means a greater likelihood of you being involved and that should be reason enough to prepare for a market action by executing a mock recall. But, if you need more convincing, we’ve put together a white paper outlining five reasons why a mock recall is a great idea.